Trials / Unknown
UnknownNCT05759897
A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
A 16-week Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HRS-7535 in Adults With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in subjects with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7535 | HRS-7535 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2023-12-21
- Completion
- 2024-01-04
- First posted
- 2023-03-08
- Last updated
- 2023-03-08
Source: ClinicalTrials.gov record NCT05759897. Inclusion in this directory is not an endorsement.